India

COVID-19 Coronavirus Pandemic – Latest Media Coverage

Oxford AstraZeneca

Latest news and video coverage curated from trusted media outlets


Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report\| Oneindia After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed.. Credit: Oneindia Duration: 03:03Published 3 days ago

You Might Like

Chinese vaccine to cost Bangladesh double of India's Oxford-AstraZeneca newKerala.com - Published on May 29, 2021Also reported by •IndiaTimes
Oxford, Pfizer vaccines 80% effective against COVID-19 variant found in India: Study Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK.. Zee News - Published on May 22, 2021Also reported by •IndiaTimes
Two shots of AstraZeneca provide 85-90% efficacy against COVID-19, suggests UK data Public Health England (PHE) said that the two doses of the Oxford/AstraZeneca COVID-19 vaccine may provide around 85% to 90% effectiveness against COVID-19 disease. Zee News - Published on May 21, 2021

Japan gives green signal to AstraZeneca, Moderna COVID-19 vaccines After the BioNTech Pfizer's COVID-19 vaccine, the Japanese government allows the use of Oxford AstraZeneca and Moderna vaccines for inoculation against coronavirus disease. Zee News - Published on May 21, 2021
Two AstraZeneca Covid shots 85-90% effective: UK real-world analysis Two doses of the Oxford/AstraZeneca Covid-19 vaccine are around 85% to 90% effective against symptomatic disease, Public Health England (PHE) said on Thursday, citing an analysis of real-world data.. IndiaTimes - Published on May 20, 2021
3-month gap between doses improves immune response: AZ vax co-developer A three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and.. IndiaTimes - Published on May 18, 2021

Study finds slightly increased blood clot rates after AstraZaneca COVID-19 shot A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19.. Zee News - Published on May 7, 2021
Powerful Indians making aggressive calls for COVID vaccines: Serum CEO Adar Poonawalla The Serum Institute chief spoke about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca COVID-19 vaccine that the.. Zee News - Published on May 1, 2021
5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh Varma New Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1. Sputnik V is the third vaccine India has.. DNA - Published on May 1, 2021